证券代码：601211 证券简称：国泰海通 公告编号：2026-005 国泰海通证券股份有限公司 关于计提资产减值准备的公告 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 根据《企业会计准则》和国泰海通证券股份有限公司（以下简称公司）会计政策的相关规定，公司及下 属子公司对截至2025年12月31日的各项需要计提减值的资产进行了初步预期信用损失评估和减值测试， 现将具体情况公告如下： 一、计提资产减值准备情况概述 经初步评估，公司2025年10-12月计提信用减值损失人民币160,397万元，计提其他资产减值损失人民币 2,582万元，合计计提资产减值损失人民币162,979万元，对净利润的影响超过公司2024年度经审计的净 利润的10%。 单位：人民币万元 ■ 注1：本年新增计提长期应收款、应收融资租赁款信用减值损失(同时新增长期应收款利息收入、融资租 赁收入)，主要是吸收合并海通证券股份有限公司（以下简称海通证券）新增租赁业务。租赁业务的盈 利模式 ...

Group 1 - The core viewpoint of the report is that Kingsoft Cloud (03896) is in a new growth phase driven by AI, with projected revenues of 9.51 billion, 11.69 billion, and 14.34 billion yuan for 2025, 2026, and 2027 respectively, and a target price of 10.03 HKD based on a dynamic PS of 3.5x for 2026 [1] - In Q3 2025, the company achieved revenue of 2.478 billion yuan, a year-on-year increase of 31.4%, with public cloud service revenue at 1.752 billion yuan, up 49.1%, and AI revenue reaching 782 million yuan, a significant increase of approximately 120% [1][2] - The company has seen a strong demand for AI, with ecosystem revenue from its partnership with Xiaomi reaching 691 million yuan, an increase of 83.8% year-on-year [1] Group 2 - In Q3 2025, the company reported adjusted operating profit of 15 million yuan and adjusted net profit of 29 million yuan, marking its first profitable quarter in adjusted terms compared to Q3 2024, indicating a continuous improvement in profitability [2] - The company completed a new round of share placement on October 2, 2025, raising approximately 2.76 billion yuan, with 80% of the funds allocated to support AI business, including infrastructure expansion and cloud service enhancement [3] - The Kingsoft Cloud Star Stream platform has undergone a strategic upgrade to a one-stop AI training and deployment platform, supporting nearly 40 different models, showcasing the company's commitment to AI business development [3]

Group 1 - The core viewpoint of the report is that Kingsoft Cloud (03896) is in a new growth phase driven by AI, with projected revenues of 9.51 billion, 11.69 billion, and 14.34 billion yuan for 2025, 2026, and 2027 respectively, and a target price of 10.03 HKD based on a dynamic PS of 3.5x for 2026 [1] Group 2 - In Q3 2025, the company achieved revenue of 2.478 billion yuan, a year-on-year increase of 31.4%, with public cloud service revenue reaching 1.752 billion yuan, up 49.1%, and AI revenue at 782 million yuan, growing approximately 120% [1] - The company reported adjusted operating profit of 15 million yuan and adjusted net profit of 29 million yuan in Q3 2025, marking its first profitable quarter in adjusted terms, indicating a continuous improvement in profitability [2] Group 3 - The company completed a new round of placement on October 2, 2025, raising approximately 2.76 billion yuan, with 80% allocated to support AI business, including infrastructure expansion and cloud service enhancement [3] - The Kingsoft Cloud Star Stream platform has undergone a strategic upgrade to a one-stop AI training and deployment platform, supporting nearly 40 different models, including Xiaomi MiMo and DeepSeek [3]

Group 1 - The core viewpoint of the report is that Mixue Group (02097) is a leading player in the domestic fresh beverage market, benefiting from a high-quality, affordable positioning and a first-mover advantage in the supply chain, which creates barriers through economies of scale [1] - The company is projected to achieve revenues of 33.7 billion, 38.1 billion, and 42.4 billion RMB for the years 2025, 2026, and 2027, respectively, with growth rates of 36%, 13%, and 11% [1] - The forecasted net profit attributable to shareholders for 2025, 2026, and 2027 is expected to be 5.934 billion, 6.779 billion, and 7.535 billion RMB, with growth rates of 34%, 14%, and 11% [1] Group 2 - The domestic fresh beverage market has significant growth potential, with the market size increasing from 187.8 billion RMB in 2018 to 517.5 billion RMB in 2023, reflecting a compound annual growth rate of 22.5% [2] - Mixue Ice City holds a dominant market share in the affordable tea beverage segment, and the overall penetration of fresh beverages in the beverage market is expected to increase [2] - The company has substantial domestic and international expansion opportunities, with potential store openings of 60,000 to 70,000 for Mixue Ice City and over 40,000 for international markets, particularly in Southeast Asia [3]

Group 1: Company Overview - The company, Mixue Group, is a leading player in the domestic ready-to-drink beverage market, known for its high-quality and affordable positioning, along with a supply chain advantage that creates barriers to entry [1] - Mixue Group operates several brands, including the tea drink brand "Mixue Ice City," the coffee brand "Lucky Coffee," and the fresh beer brand "Fulu Family," with a focus on cost advantages through direct sourcing and self-production of core ingredients [1] Group 2: Financial Projections - Revenue projections for Mixue Group are estimated to be RMB 33.7 billion, RMB 38.1 billion, and RMB 42.4 billion for the years 2025, 2026, and 2027, respectively, reflecting growth rates of 36%, 13%, and 11% [1] - The forecasted net profit attributable to shareholders for the same years is RMB 5.934 billion, RMB 6.779 billion, and RMB 7.535 billion, with growth rates of 34%, 14%, and 11% [1] Group 3: Market Potential - The domestic ready-to-drink beverage market in China has grown from RMB 187.8 billion in 2018 to RMB 517.5 billion in 2023, with a compound annual growth rate of 22.5%, indicating significant growth potential [2] - The penetration rate of ready-to-drink beverages in the beverage market is expected to increase, driven by consumer demand for fresh, healthy, and diverse flavors, as well as the rise of delivery channels [2] Group 4: Expansion Opportunities - The company has significant domestic and international expansion potential, with estimated store openings of 60,000 to 70,000 for the Mixue Ice City brand and 18,000 for the Lucky Coffee brand in China, and over 40,000 potential openings overseas, particularly in Southeast Asia [3] - The acquisition of the fresh beer brand Fulu Family allows Mixue Group to diversify its offerings and establish itself as a platform company in the beverage industry [3]

Group 1 - The meeting involved representatives from Guotai Junan Securities and Lanshi Zhongke, focusing on the latest developments and technological layout in the field of nanomaterials [1][2] - Lanshi Zhongke showcased its core technology system and competitive advantages in nanomaterials, as well as its future development plans [1] - The discussion included key technical indicators and optimization paths for materials such as lanthanum oxide, cerium oxide, and nano zinc oxide, with positive feedback on Lanshi Zhongke's technical strength and development prospects [1] Group 2 - Lanshi Zhongke expressed gratitude for the support and resource promotion from Guotai Junan Securities, highlighting the complementary nature of their core process R&D and industrialization experience with the research focus of Jiangxi Copper Research Institute [2] - The company looks forward to a site visit from the Jiangxi Copper team for further exchanges and aims to collaborate with partners in the new materials field [2]

Core Viewpoint - Cathay Securities has given a "Buy" rating to Tsunam Machine Tool China (01651), predicting significant revenue and profit growth from FY2026 to FY2028, driven by strong product capabilities and customer channels in the machine tool industry [1] Group 1: Financial Performance - For the first half of FY2026, the company achieved a revenue of approximately 2.497 billion yuan, representing a year-on-year growth of 26.2% [1] - The net profit attributable to shareholders was 502 million yuan, with a year-on-year increase of 47.7% [1] - The gross margin was 34.6%, up by 2.5 percentage points, while the net profit margin reached 20.1%, an increase of 2.9 percentage points [1] Group 2: Market Opportunities - The AI liquid cooling sector is entering a phase of bulk equipment procurement, with the company having a competitive edge in processing rapid liquid cooling connectors [2] - From January to September 2025, the company signed equipment orders with dozens of clients, accounting for about 5% of domestic order value [2] Group 3: Strategic Developments - The company is actively expanding into new fields, particularly in humanoid robotics, driven by the growing demand for small precision components due to advancements in autonomous driving and AI applications [3] - Cost reduction and efficiency improvement measures have enhanced the product's cost-effectiveness and market competitiveness, with several devices successfully applied in processing key components for humanoid robots [3] - In the same period (January to September 2025), the company secured orders for various equipment types, including automatic lathes and external cylindrical grinding machines [3]

Core Viewpoint - Cathay Securities has given a "Buy" rating to Tsunamachine China (01651), predicting significant revenue and profit growth from FY2026E to FY2028E, driven by strong product capabilities and customer channels in the machine tool industry [1] Group 1: Financial Projections - Projected revenues for FY2026E, FY2027E, and FY2028E are expected to be 5.182 billion, 5.823 billion, and 6.562 billion CNY respectively [1] - Projected net profits for FY2026E, FY2027E, and FY2028E are expected to be 1.018 billion, 1.108 billion, and 1.263 billion CNY respectively [1] - The company achieved a revenue of approximately 2.497 billion CNY in the first half of FY2026, representing a year-on-year growth of 26.2% [1] Group 2: Market Position and Product Strength - Tsunamachine China specializes in high-end CNC machine tools, including precision lathes, machining centers, and grinding machines, widely used in high-precision processing fields such as automotive and 3C [1] - The company has a gross margin of 34.6%, which is an increase of 2.5 percentage points year-on-year, and a net profit margin of 20.1%, up by 2.9 percentage points year-on-year [1] Group 3: Growth Opportunities - The AI liquid cooling sector is entering a phase of bulk equipment procurement, with the company having a competitive edge in processing rapid liquid cooling connectors [2] - The company has signed equipment orders with dozens of clients in the AI liquid cooling sector, accounting for about 5% of domestic order value from January to September 2025 [2] - The demand for small precision components is increasing due to the rapid expansion of autonomous driving and AI applications, with the company actively developing humanoid robot-related business [3] - The company has successfully applied multiple devices in processing key components for humanoid robots, including planetary roller screws and harmonic reducers [3]

Core Viewpoint - Company is rated "Buy" by Guotai Junan Securities, highlighting its position as a leading global preclinical CRO and biotechnology firm with strong technical barriers and stable revenue growth from preclinical products and services [1] Group 1: Revenue Growth and Business Model - Preclinical products and services are the foundation of the company's business, with revenue growing rapidly due to leading gene editing technologies and a high-quality humanized antibody mouse platform [2] - Sales of model animals increased from 66 million yuan in 2021 to 389 million yuan in 2024, with a CAGR exceeding 50% [2] - The company has established long-term partnerships with over 950 global partners, completing more than 6,350 drug evaluation projects, maintaining a clinical preclinical pharmacology customer retention rate above 60% [2] Group 2: Antibody Development and Growth Engines - The "Thousand Mice and Ten Thousand Antibodies" plan is entering a monetization phase, with antibody development and licensing becoming strong growth drivers [2] - Revenue from antibody development increased from 127 million yuan in 2022 to 318 million yuan in 2024, with a CAGR of 58% and a gross margin exceeding 90% in 2024 [2] - The million-level antibody sequence library provides high-quality antibody molecules for global partners and maximizes technical value through various models such as licensing and collaborative development [2]

Core Viewpoint - Company is rated "Buy" by Guotai Junan Securities, highlighting its position as a leading global preclinical CRO and biotechnology firm with strong technical barriers and stable revenue growth from preclinical products and services [1] Group 1: Revenue Growth and Business Model - Preclinical products and services are the foundation of the company's business, with revenue growing rapidly; model animal sales are projected to increase from 66 million yuan in 2021 to 389 million yuan in 2024, with a CAGR exceeding 50% [1] - The company has established long-term partnerships with over 950 global collaborators, including the top ten pharmaceutical companies, completing over 6,350 drug evaluation projects [1] - The company has a strong overseas presence, with higher average order values from international clients compared to domestic ones, enhancing its risk resistance and profitability [1] Group 2: Antibody Development and Growth Engine - The "Thousand Mice and Ten Thousand Antibodies" plan is entering a realization phase, with antibody development and licensing becoming a significant growth driver; revenue from antibody development is expected to grow from 127 million yuan in 2022 to 318 million yuan in 2024, with a CAGR of 58% [2] - The company’s innovative "antibody shelf" model breaks traditional efficiency bottlenecks in antibody development, providing high-quality antibody molecules for global partners and maximizing technical value through various collaboration models [2] - The core pipeline focuses on high-value areas, complementing collaborative pipelines and gradually realizing commercial potential, thus creating a new growth engine [2] Group 3: Catalysts - Sales of model animals are expected to exceed forecasts, and the antibody licensing business is anticipated to realize results beyond expectations [3]